MedPath

XYOSTED

These highlights do not include all the information needed to use XYOSTED safely and effectively. See full prescribing information for XYOSTED. XYOSTED (testosterone enanthate) injection, for subcutaneous useCIIIInitial U.S. approval: 1953

Approved
Approval ID

8a3d204c-be26-49e0-8599-0ac12a272e81

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2024

Manufacturers
FDA

Antares Pharma, Inc.

DUNS: 085369585

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

testosterone enanthate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54436-200
Application NumberNDA209863
Product Classification
M
Marketing Category
C73594
G
Generic Name
testosterone enanthate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 1, 2023
FDA Product Classification

INGREDIENTS (2)

SESAME OILInactive
Code: QX10HYY4QV
Classification: IACT
TESTOSTERONE ENANTHATEActive
Quantity: 100 mg in 0.5 mL
Code: 7Z6522T8N9
Classification: ACTIB

testosterone enanthate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54436-275
Application NumberNDA209863
Product Classification
M
Marketing Category
C73594
G
Generic Name
testosterone enanthate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 1, 2023
FDA Product Classification

INGREDIENTS (2)

SESAME OILInactive
Code: QX10HYY4QV
Classification: IACT
TESTOSTERONE ENANTHATEActive
Quantity: 75 mg in 0.5 mL
Code: 7Z6522T8N9
Classification: ACTIB

testosterone enanthate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54436-250
Application NumberNDA209863
Product Classification
M
Marketing Category
C73594
G
Generic Name
testosterone enanthate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 1, 2023
FDA Product Classification

INGREDIENTS (2)

TESTOSTERONE ENANTHATEActive
Quantity: 50 mg in 0.5 mL
Code: 7Z6522T8N9
Classification: ACTIB
SESAME OILInactive
Code: QX10HYY4QV
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

XYOSTED - FDA Drug Approval Details